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It has been postulated that creation of Man8GlcNAc2 isomer B (M8B) by endoplasmic reticulum (ER) -mannosidase I
constitutes a signal for driving irreparably misfolded glycoproteins to proteasomal degradation. Contrary to a previous
report, we were able to detect in vivo (but not in vitro) an extremely feeble ER -mannosidase activity in Schizosaccha-
romyces pombe. The enzyme yielded M8B on degradation of Man9GlcNAc2 and was inhibited by kifunensin. Live S.
pombe cells showed an extremely limited capacity to demannosylate Man9GlcNAc2 present in misfolded glycoproteins
even after a long residence in the ER. In addition, no preferential degradation of M8B-bearing species was detected.
Nevertheless, disruption of the -mannosidase encoding gene almost totally prevented degradation of a misfolded
glycoprotein. This and other conflicting reports may be best explained by assuming that the role of ER mannosidase
on glycoprotein degradation is independent of its enzymatic activity. The enzyme, behaving as a lectin binding
polymannose glycans of varied structures, would belong together with its enzymatically inactive homologue Htm1p/
Mnl1p/EDEM, to a transport chain responsible for delivering irreparably misfolded glycoproteins to proteasomes.
Kifunensin and 1-deoxymannojirimycin, being mannose homologues, would behave as inhibitors of the ER mannosidase
or/and Htm1p/Mnl1p/EDEM putative lectin properties.
INTRODUCTION
Cells have to continuously monitor whether newly synthe-
sized glycoproteins are in the process of proper folding or
whether, alternatively, they are irreparably misfolded
(Trombetta and Parodi, 2003). Both folding intermediates
and irreparably misfolded species may be retained in the
endoplasmic reticulum (ER) as a consequence of their asso-
ciation with the ER unconventional chaperones calnexin
(CNX) and calreticulin (CRT) (Parodi, 2000). These lectins
specifically recognize monoglucosylated N-glycans formed
either by partial deglucosylation of the transferred glycan
(removal of residues m and n from Glc3Man9GlcNAc2; Fig-
ure 1) or by UDP-Glc:glycoprotein glucosyltransferase (GT)-
mediated reglucosylation of the totally deglucosylated gly-
can (readdition of Glc l to Man g; Figure 1). However, as
permanent residence of misfolded species in the ER has
deleterious effects on cell viability, there are mechanisms for
their recognition and subsequent diversion to degradation.
It has been proposed that a particular glycan structure
(Man8GlcNAc2 isomer B or M8B; Figure 1) could be the
signal by which cells recognize that a glycoprotein molecule
is unable to reach its native three-dimensional structure
(Knop et al., 1996; Jakob et al., 1998). Because M8B is pro-
duced by ER mannosidase I, a slow-acting enzyme com-
pared with the activity of ER processing glucosidases, it has
been speculated that if a protein folds extremely slowly or if
it is irreparably misfolded, it would display the particular
M8B structure that in turn would be recognized by an ER
lectin specific for that glycan and thus diverted to proteaso-
mal degradation. Evidence for the involvement of ER man-
nosidase I in misfolded glycoprotein degradation was pro-
vided by several experimental observations, as for example,
that ablation of the S. cerevisiae ER mannosidase encoding
gene drastically reduced the rate of misfolded glycoprotein
degradation and that the same effect resulted from addition
of ER mannosidase I inhibitors (kifunensin, KFN or 1-de-
oxymannojirimycin, DMJ) to mammalian cells (for review,
see Cabral et al., 2001, and references therein). Concerning
the postulated lectin, a presumably enzymatically ER man-
nosidase I homologue has been identified in S. cerevisiae
(variously referred to as Htm1p or Mnl1p) and in mamma-
lian cells (referred to as ER degradation enhancing -man-
nosidase-like protein or EDEM) (Hosokawa et al., 2001; Ja-
kob et al., 2001; Nakatsukasa et al., 2001). Ablation of
Htm1p/Mnl1p encoding gene in yeast or reduction of
EDEM expression by the RNA interference technique in
mammalian cells drastically reduced disposal of misfolded
glycoproteins, whereas overexpression of EDEM increased
the degradation rate (Hosokawa et al., 2001; Molinari et al.,
2003; Oda et al., 2003). Htm1p/Mnl1p/EDEM has not been
isolated yet, so its putative lectin capacity has not been
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confirmed. The human genome codes for two additional
EDEM-like proteins. Characterization of the so called
EDEM2 revealed that it displays no mannosidase activity
and that its overexpression in mammalian cells enhances
misfolded glycoprotein degradation (Mast et al., 2005; Oli-
vari et al., 2005). Both the Saccharomyces cerevisiae and Schizo-
saccharomyces pombe genomes code for only one Htm1p/
Mnl1p/EDEM protein. On the other hand, in S. cerevisiae
there is an alternative, proteasome-independent pathway for
ER-associated degradation (ERAD) (Umebayashi et al.,
2001).
The model by which N-glycan structural modifications
introduced by ER -mannosidase activity could play an
essential role in driving irreparably misfolded glycoproteins
to degradation is extremely attractive but presents several
severe inconsistencies that will be discussed below in ex-
tenso. To further study the controversial role of ER manno-
sidase on ERAD of misfolded glycoproteins, we chose the
fission yeast S. pombe because this yeast, contrary to S.
cerevisiae, displays a quality control of glycoprotein folding
similar to that present in mammalian cells. The fission yeast
expresses a robust GT activity responsible for the glucosy-
lation of folding intermediates and irreparably misfolded
species (Ferna´ndez et al., 1994). S. pombe GT is up-regulated
under conditions of ER stress and ablation of its encoding
gene triggers the so-called unfolded protein response (Fer-
na´ndez et al., 1996; D’Alessio et al., 1999). In addition, GT
was shown to be essential for cell viability under conditions
of severe ER stress (Fanchiotti et al., 1998). What made S.
pombe a particularly interesting model system for the pur-
pose of our work is that according to a previous report, no
ER mannosidase activity could be detected in it, both in in
vivo and in vitro assays (Ziegler et al., 1994). Work here
reported shows that this yeast displays indeed an extremely
feeble ER mannosidase activity that could be detected in
vivo but not in vitro. The extremely limited capacity to
demannosylate Man9GlcNAc2 glycans present in misfolded
glycoproteins severely questions the accepted role of ER
-mannosidases on ERAD.
MATERIALS AND METHODS
Materials
[14C]Glc (301 Ci/mol) was from PerkinElmer Life and Analytical Sciences
(Boston, MA). N-Methyldeoxynojirimycin (NMDNJ), KFN, and DMJ were
from Toronto Biochemicals Toronto, Ontario, Canada. N-Carboxybenzoxyl-
leucinyl-leucinyl-leucinal (MG132) and clasto-lactacystin--lactone (lactacys-
tin) were from Calbiochem (San Diego, CA). Restriction enzymes and other
enzymes used in DNA procedures were from PerkinElmer Life and Analyt-
ical Sciences. Dithiothreitol (DTT) and endo--N-acetylglucosaminidase H
(Endo H) were from Sigma-Aldrich (St. Louis, MO).
Strains and Culture Media
The S. pombe strain was ADp (h, ade6, M216, leu1-32, ura4-D18). Growth
medium contained 0.5% yeast extract (Difco, Detroit, MI), 3% glucose, and 75
mg/ml adenine. Minimal medium was as described previously (Alfa et al.,
1993). The S. cerevisiae strain used was HH3 (MAT, lys2-801, ade2-101, his3-
200, trp1-1, ura3-52, and leu2-1).
Antisera. S. cerevisiae caboxypeptidase Y (CPY) and S. pombe CNX antisera
were generous gifts from Drs. Reid Gilmore (University of Massachusetts,
Worcester, MA) and Luis Rokeach (Universite´ de Montre´al, Montre´al, Que-
bec, Canada), respectively.
Labeling, Isolation, and Structural Analysis of N-Glycans
Cells were labeled and N-glycans isolated as described previously (Ferna´ndez
et al., 1994). Briefly, cells (0.3 g) were resuspended in 1 ml (total volume) of 1%
yeast nitrogen base (YNB; Difco) to which 100 l of 50 mM Glc containing 150
Ci of [14C]Glc was added. Incubation times were as described in text. Where
indicated 100 l of 0.5 M Glc was added for chasing the label. KFN, DMJ, and
NMDNJ (2.5 mM final concentrations) and lactacystin (50 M final concen-
tration) were added 30 min and DTT (5 mM final concentration) 5 min before
labeling. In experiments described in Figure 7, A–C, cycloheximide (0.1
mg/ml final concentration) together with Glc (50 mM final concentration)
were added 15 min after addition of the label and DTT concentration was
raised to 10 mM after 35 min of chase. In experiment described in Figure 7D,
DTT (5 mM final concentration) was added 70 min before the label and the
drug concentration was raised to 10 mM 5 min before [14C]Glc addition.
Acetolysis and paper electrophoresis in 0.1 M sodium molybdate, pH 5.0,
were as described previously (Engel and Parodi, 1985). Chromatography was
performed on Whatman no. 1 paper with solvents A, 1-propanol/nitrometh-
ane/water (5:2:4); B, 1-butanol/pyridine/water (4:3:4); C, 1-butanol/pyri-
dine/water (10:3:3); and D, 2-propanol/acetic acid/water (29:4:9).
Gene Disruptions
Disruption of spmns1. A 1390-base pair fragment of gene spmns1 (gi:
6322591) was amplified using genomic DNA as template and primers 5-
TAACCGCGGATGGTTAAACGAAGGACTG-3 and 5-CAACTCGAGCT-
TCGACTCTACACTATC-3 and cloned in the pBluescript KSII() vector.
Fragment XbaI-BglII corresponding to bases 550–816 was replaced with gene
ura4. A 2946-base pair fragment liberated with SacII and XhoI was used to
transform S. pombe cells. Transformants were isolated in minimal medium
supplemented with adenine and leucine. Correct integration was checked by
Southern blotting analysis and by PCR with a primer from ura4 (5-TTT-
TCATCCCCTCAGCTC-3) and from spmns1 (5-TAACTCGAGCACCGTG-
TACAGGTCC-3). Disruption of spmns2 and spmnl1. The same procedures
were used for disruption of these genes, but in the first case amplification
primers were 5-GGACCTGCAGATGACACTCTTCCCAGTA-3 and 5-CT-
TCTCGAGGGCTCTCCAACTAGTTGG-3 (2985-base pair fragment) and in
the second 5-TATATACCGCGGATGGGTAGCTTGCACTC-3 and 5-
CAACTCGAGTTCACCATCCGTGATG-3 (2205 base pairs fragment). In the
first case, a HindII fragment corresponding to bases 428-2324 and in the
second a ClaI-XbaI fragment corresponding to bases 863-1600 was replaced
with gene ura4. In the first case, a 2946-base pair fragment liberated with PstI
and XhoI and in the second a 3227-base pair fragment liberated with SacII and
XhoI were used to transform S. pombe cells. Correct integration was checked
Figure 1. Glycan structures. The figure represents the glycan
transferred to proteins in wild-type S. pombe cells
(Glc3Man9GlcNAc2). Lettering corresponds to the order of residue
addition in the synthesis of the dolichol-P-P derivative. Numbers
between monosaccharides correspond to the carbon atoms involved
in the respective linkages. M8A lacks residues g and l-n, M8B
residues j and l-n, and M8C residues k-n. The Man7GlcNAc2 isomer
formed in S. pombe lacks residues i and k-n. The glycan transferred
in MadIA214cells (Man5GlcNAc2) lacks residues h-n.
S. pombe ER-associated Degradation
Vol. 16, October 2005 4715
by Southern blotting analysis and by PCR using primers from ura4 5-TTT-
TCATCCCCTCAGCTC-3 in the first case and 5-TGCTCCTACAACAT-
TACC-3 in the second and primers from spmns2 5-TAACTCGAGCACCGT-
GTACAGGTCC-3 and from spmnl1 5-TTGACGCACAGAGACGTTG-3.
Sequence Analysis
The program used for calculating similarities between sequences was the
Water from the European Bioinformatics Institute (www.ebi.ac.uk) using
BLOSUM62 as matrix.
In Vitro -Mannosidase Assays
S. cerevisiae and S. pombe microsomes were prepared as described previously
(Ferna´ndez et al., 1994). One milligram of microsomal proteins was incubated
with 7000 cpm of [14C-Man]Man9GlcNAc in 50 mM PIPES buffer, pH 7.1, 1
mM CaCl2 and 0.4% Lubrol in a total volume of 100 l. After 30 min at room
temperature, 200 ml of methanol was added, tubes were centrifuged at low
speed, and supernatants were spotted on Whatman no. 1 paper. Chromato-
grams were developed with solvent D.
S. cerevisiae CPY* Expression in S. pombe
S. cerevisiae gene encoding for caboxypeptidase Y (CPY) was amplified using
Pfu polymerase, genomic DNA as template and primers 5-CGTCTCGAGAT-
GAAAGCATTCACC-3 and 5-ATACCCGGGTTATAAGGAGAAACCAC-
CGTG-3 and cloned in vector pBluescript KS II (). Base 763 was mutated (G
to A) by PCR with primers 5-CATCGCTAGGGAATCCTAC-3 and 5-TG-
GAAATCTTGGCCCTTG-3. The product (encoding CPY*) was sequenced to
check the mutation introduced and cloned in sites XhoI and SmaI of S. pombe
expression vector pREP3X, which was used to transform wild-type and
mutant S. pombe strains as described previously (Fanchiotti et al., 1998).
CPY* degradation in S. pombe
Cells expressing S. cerevisiae CPY* were grown in SC medium (0.67% YNB
[Difco], 2% Glc, and 70 mg/ml adenine and uracyl) at 28°C up to an OD600 of
0.2–0.3. About 15 OD600 of cells was withdrawn, centrifuged, and resus-
pended in 0.6 ml of SC medium but without Met (YNB without amino acids;
Difco). Cells were incubated for 30 min, and 300 Ci of EasyTaq Express
Labeling Mix (PerkinElmer Life and Analytical Sciences) was added. Where
indicated, KFN, DMJ, lactacystin, and MG132 (final concentrations, 2.5 mM
the first two drugs and 50 M the last two) were added 30 min before the
label. Cycloheximide (1 mM final concentration) was added 15 min after
the label, and 200-l aliquots were withdrawn 0 and 30 min after addition of
the protein synthesis inhibitor. Two hundred milliliters of 2 stop buffer (2 M
sorbitol, 50 mM Tris-HCl, pH 7.5, 40 mM NaN3, and 20 mM DTT) was added
to the samples, which were then frozen to –70°C until extract preparation. For
this purpose 5 l of lysing enzymes (10 mg/ml) was added, and samples were
incubated for 25 min at 30°C. Trichloroacetic acid (5% final concentration) was
added and samples were maintained on ice for 30 min. Samples were then
centrifuged, and pellets were washed with ice-cold acetone. Pellets were
resuspended in 100 l of boiling buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA,
and 1% SDS). Resuspended samples were sonicated, stirred in a Vortex with
glass beads and boiled for 4 min. Immunoprecipitation buffer (1 ml of 50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Tween 20, and 0.1 mM EDTA) was then
added. The extracts were centrifuged and to supernatants CPY antiserum was
added. Samples were then incubated overnight at 4°C with gentle stirring.
Protein A-Sepharose was then added, samples were incubated for 3 h and
then centrifuged at low speed. Supernatants were withdrawn and CNX
antiserum was added to them. Pellets of the anti-CPY immunoprecipitations
were washed first with immunoprecipitation buffer and then with the same
solution but containing in addition 2 M urea, 0.1% SDS, and finally with Tris
buffer saline. Pellets were then heated at 100°C for 5 min with 2 sample
buffer (125 mM Tris-HCl, pH 6.8, 20% glycerol, 10% -mercaptoethanol, and
6% SDS). Supernatants were run on SDS-PAGE, dried, and CPY* quantified
with a PhosphoImager. Immunoprecipitations with CNX antiserum were
likewise performed. Amounts of CNX occurring under different conditions
were used to normalize recovery of CPY* in the samples.
RESULTS
S. pombe Expresses an -Mannosidase
As mentioned above, a previous report indicated that S.
pombe cells do not express an ER mannosidase (Ziegler et al.,
1994). Nevertheless, incubation of live wild-type S. pombe
cells with 5 mM radioactive Glc for 15 min led to formation
of Endo H-released protein-linked Man9GlcNAc and
Man8GlcNAc. The proportion of the smaller compound
ranged between 5 and 8% (Figure 2A). Practically no larger
glycans were observed after a 15-min incubation but Golgi
elongation of above-mentioned N-glycans was observed on
chasing cells with a 10-fold higher unlabeled Glc concentra-
tion (Figure 2B). Man8GlcNAc2 was also formed when cells
were labeled at 50 mM Glc concentration.
Identification of the -Mannosidase Encoding Gene
There are three proteins encoded in the S. pombe genome
with potential -mannosidase activity: Spmns1p
(gi48474992), Spmns2p (gi:19114891), and Spmnl1p
(gi:19115346) (Sp stands for S. pombe). They, respectively,
show higher similarity to S. cerevisiae ER -mannosidase
(56.8%), to vacuolar mannosidase (65.1%), and to the man-
nosidase-like protein (otherwise referred to as Htm1p/
Mnl1p/EDEM) (45.0%).
Their encoding genes were individually disrupted and
resulting mutants assayed for formation of protein-linked
glycans. Only the mutant lacking Spmns1p showed no for-
mation of Man8GlcNAc2 (Figure 3, A–D). Transcription of
the Htm1p/Mnl1p/EDEM-encoding gene (spmnl1) in
wild-type cells was confirmed by reverse transcription-PCR.
Structural Characterization of Man8GlcNAc2
Man8GlcNAc was submitted to acetolysis, a procedure that
preferentially cleaves (1,6) bonds between Man units, and
resulting fragments were separated on paper chromatogra-
Figure 2. S. pombe expresses an -mannosidase activity. (A) S.
pombe cells were incubated for 15 min with 5.0 mM labeled Glc, and
whole cell Endo H-released glycans were run on paper chromatog-
raphy with solvent A. (B) The same as in A, but cells were chased
with 50 mM Glc for 45 min. Standards: 9, Man9GlcNAc; and 8,
Man8GlcNAc. For further details, see Materials and Methods.
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phy. Labeled compounds migrated as Man4GlcNAc and
Man2 standards (Figure 4A). Reduction of the latter fol-
lowed by paper electrophoresis in sodium molybdate, pH
5.0, revealed that about half of the label remained at the
origin, whereas the rest migrated to the anode (Figure 4B).
As (1,2)-linked reduced Man2 migrates under the assay
conditions, whereas the (1,3)-linked isomer does not, re-
sults obtained indicate that Man8GlcNAc2 isomer B (M8B)
was produced by S. pombe Spmns1p mannosidase (Figure 1)
(Parodi et al., 1983). A mixture of M8B and M8C isomers
(Figure 1) was obtained if the Glc concentration during the
labeling period of wild-type cells was reduced to 0.5 mM.
On the other hand, the Spmns1p minus mutant only yielded
M8C under similar labeling conditions. Because M8C but
not M8B is an intermediate in the synthesis of dolichol
derivatives, these results indicate that under low Glc con-
centrations, S. pombe cells, the same as the mammalian cells,
synthesize and transfer to proteins a sizable proportion of
incomplete glycans (Gershman and Robbins, 1981; Rearick et
al., 1981).
The Effect of -Mannosidase Inhibitors
KFN and DMJ were tested as potential Spmns1p inhibitors.
Wild-type cells were preincubated with the compounds at a
Figure 3. Synthesis of M8B in wild-type
and mutant S. pombe cells. Wild type (A),
spmns1 (B), spmns2 (C), and spmnl1 (D)
mutant cells were labeled for 15 min with 5
mM labeled Glc, and whole cell, Endo H-
sensitive glycans were run on paper chroma-
tography with solvent A. Standards: 9,
Man9GlcNAc; and 8, Man8GlcNAc. For fur-
ther details, see Materials and Methods.
Figure 4. Structures of glycans. (A)
Man8GlcNAc synthesized by wild-type S.
pombe cells was submitted to acetolysis and
run on paper chromatography with solvent
B. (B) Man2 in A was reduced with NaBH4
and run on paper electrophoresis with 0.1 M
sodium molybdate, pH 5.0. (C) Paper chro-
matography of acetolysis products of
Man7GlcNAc. (D) Paper electrophoresis of
reduced Man2 isolated from chromatogram
shown in Figure 4C. Standards: 1, Man; 2,
Man2, 3, Man3, 4, Man3GlcNAc; and 5,
Man4GlcNAc. For further details, see Materi-
als and Methods.
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2.5 mM concentration for 30 min before addition of labeled
glucose. As depicted in Figure 5, A–C, whereas KFN
significantly inhibited M8B formation, absolutely no effect
was observed upon addition of DMJ. No inhibition was
observed also when 2.5 mM DMJ was tested under similar
in vivo conditions as S. cerevisiae ER -mannosidase in-
hibitor. Because the DMJ concentration used is 50-fold
higher than the IC50 of the drug for the last enzyme as
determined in cell free assays (Jelinek-Kelly et al., 1985),
this indicates that penetration of DMJ into the budding
yeast ER, and probably also into that of S. pombe, is
severely impeded.
Subcellular Localization of Spmns1p
Wild-type cells were incubated with 5 mM labeled glucose
for 15 min in the presence of DTT. This compound effec-
tively prevents proper folding, and thus ER exit, of glyco-
proteins by interfering with disulfide bond formation (Si-
mons et al., 1995). Secretion of disulfide-free proteins is not
affected, but as already reported and as will be further
shown below, the majority of glycoproteins synthesized in S.
pombe have disulfide bonds (Ferna´ndez et al., 1998). M8B was
still formed under the experimental conditions used, thus
indicating that Spmns1p localized to the ER (Figure 6A). To
confirm the subcellular localization of S. pombe -mannosi-
dase, we took advantage of the presence of GT in this yeast
ER: an alg6 mutant was incubated for 15 min with labeled
glucose in the presence of 5 mM DTT and 2.5 mM NMDNJ,
a glucosidase II inhibitor. In alg6 mutants, Man9GlcNAc2
instead of Glc3Man9GlcNAc2 is transferred to proteins because
they lack the enzyme that transfers the first Glc residue from
Glc-P-dolichol to Man9GlcNAc2-P-P-dolichol. Compounds mi-
grating in the positions expected for Glc1Man9GlcNAc,
Man9GlcNAc, and Glc1Man8GlcNAc were formed (Figure 6B).
Rather surprisingly, no Man8GlcNAc occurred in the chro-
matogram. Compounds migrating as Glc1Man9GlcNAc,
Man9GlcNAc and Glc1Man8GlcNAc were individually rerun
on paper chromatography to get a better separation and sub-
mitted then to strong acid hydrolysis followed by monosac-
charide separation by paper chromatography. As shown in
Figure 6, C–E, compounds migrating as Glc1Man9GlcNAc and
Glc1Man8GlcNAc contained labeled Glc and Man units,
whereas that migrating as Man9GlcNAc only contained the last
residues. Formation of Glc1Man8GlcNAc2 indicated that S.
pombe -mannosidase (Spmns1p) and GT shared the same
subcellular compartment.
Glycan Processing in Misfolded Glycoproteins
Figure 2, A and B, shows that a minimal proportion of
N-glycans was processed to Man8GlcNAc2 under normal
folding conditions. To study ER processing of N-glycans
present in misfolded species, S. pombe cells were incubated
with 5 mM [14C]Glc for 15 min in the presence of DTT and
lactacystin to prevent protein folding and degradation, re-
spectively. Contrary to what happens in S. cerevisiae, S.
pombe wild-type cells are freely permeable to the proteasome
inhibitor. Cells were then chased with 50 mM Glc, and 0.15
mg/ml cycloheximide was added to hinder further protein
synthesis and thus N-glycosylation. Samples were with-
drawn 0, 15, 45, and 90 min after the chase. The pattern of
the N-glycans of the 0-min chase sample was similar to that
shown in Figure 2A, whether incubation had been per-
formed in the presence or absence of DTT. The sample
obtained after 45-min chase in presence of the drug showed
little if any Golgi elongation of N-glycans (Figure 7A) and
the presence of both Man8GlcNAc and Man7GlcNAc in ad-
dition to Man9GlcNAc. No Man6GlcNAc was detected. The
pattern yielded by cells pulse chased in the absence of DTT
revealed a normal Golgi processing of glycans (Figure 7B).
This showed that DTT had effectively prevented ER exit of
most glycoproteins. The relative proportions of
Man9GlcNAc, Man8GlcNAc, and Man7GlcNAc in the sam-
ples are represented in Figure 7C. It may be observed that
the rate of Man9GlcNAc2 processing gradually decreased
and finally completely ceased although, as shown in Figure
7, A and B, glycoproteins were still in the ER after the 45-min
chase as they did not show a significant Golgi processing.
Moreover, DTT inactivation of ER -mannosidase was ruled
out by preincubating cells for 70 min in the presence of the
Figure 5. Effect of -mannosidase inhibitors on S. pombe -man-
nosidase (Spmns1p). (A) S. pombe wild-type cells were incubated for
15 min with 5 mM labeled Glc, and whole cell Endo H-released
glycans were run on paper chromatography with solvent A. In B
and C, 2.5 mM (final concentration) of KFN or DMJ, respectively,
were added 30 min before the label. Standards: 9, Man9GlcNAc; and
8, Man8GlcNAc. For further details, see Materials and Methods.
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Figure 6. Subcellular localization of S.
pombe -mannosidase (Spmns1p). (A) S.
pombe wild-type cells were incubated for 15
min with 5 mM labeled Glc, and whole cell
Endo H-released glycans were run on paper
chromatography with solvent A. DTT (5 mM
final concentration) was added 5 min before
the label. (B) S. pombe alg6 mutant were pre-
incubated with 2.5 mM NMDNJ for 30 min
and 5 mM DTT for 5 min and incubated for
15 min with 5 mM labeled Glc. Whole cell Endo
H-released glycans were run on paper chroma-
tography with solvent A. Material running
between 27 and 29 cm (Glc1Man9GlcNAc), 31
and 32 cm (Man9GlcNAc), and 33 and 35
(Glc1Man8GlcNAc) in B was eluted and run
for a second time on paper chromatography
with solvent A. Material running as
Glc1Man9GlcNAc (C), as Man9GlcNAc (D),
and as Glc1Man8GlcNAc (E) was submitted to
strong acid hydrolysis (1 N HCl for 4 h at
100°C) and run on paper chromatography with
solvent C. Standards: 1–9, Glc1Man9GlcNAc; 9,
Man9GlcNAc; 1–8, Glc1Man8GlcNAc; 8,
Man8GlcNAc; 2, Glc; and 1, Man. For further
details, see Materials and Methods.
Figure 7. S. pombe ER processing of glycans
in misfolded glycoproteins. S. pombe wild-
type cells were preincubated with lactacystin
(50 M final concentration) for 30 min and
DTT (5 mM final concentration) for 5 min and
incubated with 5 mM labeled Glc for 15 min.
Glc concentration was then raised to 50 mM
with unlabeled Glc and cycloheximide (0.15
mg/ml final concentration) was added. Sam-
ples were withdrawn 0, 15, 45, and 90 min
after the chase. DTT concentration was raised
to 10 mM 35 min after the chase. (A) Whole
cell glycans Endo H-released from the 45-min
chase sample. (B) Same as A, but cells were
incubated in the absence of DTT. (C) Proportion
of Man9GlcNAc (full circles), Man8GlcNAc
(full triangles), and Man7GlcNAc (full
squares) in the samples. Data in empty sym-
bols correspond to a sample incubated in the
absence of lactacystin. (D) Cells were incu-
bated with DTT (5 mM final concentration) for
65 min, the drug concentration was then
raised to 10 mM and 5 min later 5 mM labeled
Glc was added. Incubation lasted for 15 min.
Whole cell Endo H-released glycans were run
with solvent A. Standards: 9, Man9GlcNAc;
and 8, Man8GlcNAc. For further details, see
Materials and Methods.
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drug followed by a 15-min pulse with [14C]Glc (Figure 7D).
The most plausible explanation for results shown in Figure
7C is that misfolded glycoproteins had migrated to an ER
domain lacking -mannosidase activity. Cells pulsed chased
in the presence or absence of lactacystin yielded almost
identical proportions of Man9GlcNAc2, Man8GlcNAc2, and
Man7GlcNAc2 after the 90-min chase (Figure 7C). Because
lactacystin but not DTT hindered proteasomal degradation
and substantial degradation of glycoproteins unable to
properly fold is expected to had occurred in the absence of
the former drug after a 90-min chase (see below), this result
indicates that no preferential degradation of misfolded gly-
coprotein-linked M8B over Man9GlcNAc2 or Man7GlcNAc2
had occurred.
Structural characterization of Man7GlcNAc was per-
formed as described above for Man8GlcNAc. Acetolysis of
Man7GlcNAc yielded Man4GlcNAc2, Man2, and Man (Fig-
ure 4C). Further reduction of the disaccharide followed by
paper electrophoresis in 0.1 M sodium molybdate, pH 5.0,
revealed that the compound was Man(1,3)Man (Figure
4D). The structure of Man7GlcNAc is depicted in Figure 1. S.
pombe ER -mannosidase seemed to have, therefore, the
same specificity as the S. cerevisiae enzyme (Herscovics et al.,
2002). From results here presented it may be concluded that
although the fission yeast had an extremely limited capacity
to demannosylate N-glycans in misfolded glycoproteins,
both M8B and Man7GlcNAc2 were produced on ER process-
ing of glycans. Moreover, even this last compound, which
was the smallest yielded by ER processing, displayed the
acceptor Man unit involved in GT-mediated reglucosylation
(residue g, Figure 1).
In Vitro Assay of S. pombe ER -Mannosidase:
Comparison with S. cerevisiae
S. pombe and S. cerevisiae microsomal membranes were in-
cubated with [14C-Man]Man9GlcNAc under identical condi-
tions, the reactions stopped with 66% methanol, and the
supernatants run on paper chromatography. Only S. cerevi-
siae microsomes produced Man (Figure 8A). Although the
proportion of label in the monosaccharide (12%) indicated
that the reaction had reached completion in the case of the
budding yeast, absolutely no labeled monosaccharide was
produced by S. pombe microsomes. Mixed membrane exper-
iments discarded the presence of an inhibitor or a strong
protease in the fission yeast microsomes. Moreover, the
same result was obtained when a strong antiproteolytic
cocktail was used for S. pombe microsome preparation. A
previous report also communicated that in vitro assays had
failed to detect S. pombe ER -mannosidase (Ziegler et al.,
1994). To further compare S. cerevisiae and S. pombe ER
-mannosidase activities, we incubated the former cells with
labeled [14C]Glc under conditions identical to those de-
scribed in Figure 2A for the latter cells, but for 5 min instead
of 15 min. As depicted in Figure 8B, the pattern of N-glycans
was composed of 80% Man8GlcNAc and almost equal
proportions of Man9GlcNAc and Man7GlcNAc. S. cerevisiae
had, therefore, at least more than one order of magnitude
higher capacity than S. pombe to process N-linked
Man9GlcNAc2.
CPY* Degradation in S. pombe
The extremely feeble ER -mannosidase activity present in
S. pombe, that even after 90 min could not degrade 35% of
Man9GlcNAc2 present in misfolded glycoproteins, sug-
gested that the enzyme might not be related to ERAD in the
fission yeast. To test this possibility, we expressed in S.
pombe a mutant of S. cerevisiae carboxypeptidase Y unable to
properly fold (CPY*). Cells were pulsed for 30 min with
[35S]MetCys and chased. CPY* degradation was followed
by immunoprecipitation, SDS-PAGE, and autoradiography.
As depicted in Figure 9, 61% of CPY* had disappeared
from wild-type cells after a 30-min chase. A similar value
has been reported for degradation of the same glycoprotein
in S. cerevisiae after the same chase period (Jakob et al., 1998).
A sharply decreased degradation was observed when CPY*
was expressed in Spmns1p or Spmnl1p minus mutants, the
same as has been described for S. cerevisiae (Figure 9). These
results showed that indeed the presence of ER -mannosi-
dase and of the -mannosidase-like protein (Htm1p/
Mnl1p/EDEM) was fundamental for misfolded glycopro-
tein degradation also in S. pombe. CPY* degradation was
totally or almost totally prevented in the presence of KFN,
an effective ER -mannosidase inhibitor, or of the proteaso-
mal inhibitors lactacystin or MG132 (Figure 9). Neither DMJ
nor DTT modified the extent of degradation of CPY* ex-
pressed in wild-type cells. The lack of effect of the former
drug was expected, because it did not inhibit in vivo
Figure 8. In vitro assay of S. pombe ER -mannosidase. Compari-
son with S. cerevisiae. (A) S. pombe (full circles) and S. cerevisiae
(empty circles) microsomes were incubated with [14C-
Man]Man9GlcNAc, two volumes of methanol were added and the
supernatants run on paper chromatography with solvent D. (B) S.
cerevisiae cells were incubated for 5 min with 5 mM labeled Glc, and
whole cell Endo H-released glycans were run on paper chromatog-
raphy with solvent A. Standards: 9, Man9GlcNAc; 8, Man8GlcNAc;
7, Man7GlcNAc; and 1, Man. For further details, see Materials and
Methods.
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Spmns1p activity, probably because an impediment in the
penetration into the ER lumen (Figure 5C).
DISCUSSION
Here, we show that, contrary to a previous report (Ziegler et
al., 1994), S. pombe displays an -mannosidase that localizes
to the ER and we have identified its encoding gene. The
enzyme seemed to be inhibited by KFN and to display the
same specificity as its homologue from S. cerevisiae because
it also produced first M8B and then the same Man7GlcNAc2
isomer upon Man9GlcNAc degradation.
The most remarkable feature of S. pombe ER -mannosi-
dase is the feeble activity that it displays in vivo and our and
others inability to detect its activity in in vitro assays
(Ziegler et al., 1994). Triggering misfolding of newly synthe-
sized glycoproteins by DTT addition resulted in hindering
their exit from the ER and in a limited conversion of
Man9GlcNAc2 to M8B and Man7GlcNAc2. After an initial
burst of Man9GlcNAc2 degradation, all activity on mis-
folded glycoproteins ceased probably due to migration of
the latter to ER domains lacking -mannosidase. This result
suggests that M8B might not be a signal for diversion of
misfolded glycoproteins to degradation in S. pombe. Al-
though in this yeast, the same as in other cells, the propor-
tion of misfolded glycoproteins that are degraded through
the glycan- and proteasome-dependent and proteasome-in-
dependent ERAD pathways is unknown, it should be ex-
pected that even if the former represented a minor pathway
compared with the independent pathway, degradation of
Man9GlcNAc2 linked to misfolded glycoproteins to
Man8GlcNAc2 should have been fully completed after 90
min and not stopped at a 35% level after 45 min. An exclu-
sive demannosylation of glycoproteins following the depen-
dent pathway (i.e., bearing the 35% of glycans degraded) is
highly unlikely because no ER mannosidase able to distin-
guish between glycoproteins that follow the alternative deg-
radation pathways has been described so far. In fact, all ER
-mannosidases characterized already have been shown not
to sense the conformational or soluble or membrane-bound
status of the protein moieties. Exactly the same proportion of
Man9GlcNAc2, M8B, and Man7GlcNAc2 glycans was pro-
duced under conditions allowing or not glycoprotein pro-
teasomal degradation. These results also suggest that M8B
might not be a signal for diverting misfolded glycoproteins
to degradation, although this conclusion is valid only if the
glycan- and proteasome-dependent ERAD pathway repre-
sents a relatively major pathway. S. pombe had a much lower
capacity to process Man9GlcNAc than S. cerevisiae: in vitro
assays in which all the labeled glycan had been converted to
M8B with microsomes prepared from the budding yeast
failed to release any detectable radioactivity when S. pombe
membranes were used. Moreover, 90% of Man9GlcNAc2
had been processed to M8B and Man7GlcNAc2 after a 5-min
incubation of S. cerevisiae cells with labeled glucose, whereas
a 15-min incubation of S. pombe cells only showed 5–8% of
glycan conversion. It is unknown for the moment whether
the extremely low -mannosidase activity observed in S.
pombe is a consequence of low levels of enzyme expression,
or, alternatively, of an intrinsically poor activity of the pro-
tein. It is possible that our and others inability to detect its
activity in cell free assays could be a consequence of a
significantly high Km value for the substrate used
(Man9GlcNAc).
It may be speculated that the sharp differences observed
between S. pombe and S. cerevisiae capacities for
Man9GlcNAc2 processing might reflect the absence of a gly-
can- and proteasome-dependent ERAD pathway in the
former yeast. This happened not to be the case because S.
cerevisiae CPY* expressed in wild-type S. pombe cells was
degraded to the same extent as in the budding yeast after a
30-min period (Jakob et al., 1998). Ablation of genes coding
for -mannosidase or for the mannosidase-like protein
(Htm1p/Mnl1p/EDEM) (spmns1 or spmnl1 genes, respec-
tively) resulted, the same as in S. cerevisiae, in a drastic
reduction in CPY* degradation. This last process was also
hindered upon addition of the -mannosidase inhibitor KFN
or of proteasome inhibitors lactacystin and MG132 but not of
DMJ or DTT. The differential effects of KFN and DMJ agree
with their differential capacities to inhibit in vivo Spmns1p
activity. As mentioned above, penetration of DMJ into S.
pombe ER is probably severely hindered. DMJ at 1 mM
concentration, that is, a concentration 50-fold higher than the
IC50 of the drug for the mammalian cell ER -mannosidase
I, effectively delayed misfolded glycoprotein degradation in
those cells (Tremblay and Herscovics, 1999; Tokunaga et al.,
2000; Wilson et al., 2000). This strongly suggests a facilitated
penetration of DMJ into the mammalian cell ER lumen.
It is evident that M8B cannot be per se a signal for divert-
ing misfolded glycoproteins to proteasomal degradation in
S. cerevisiae. Although it is by far the main glycan produced
in the ER in this yeast, all glycans transferred to newly
synthesized polypeptide chains are converted to it in the ER
in all glycoproteins, even in those that fold properly (Byrd et
al., 1982). That is, no discrimination between properly
folded, irreparably misfolded, and folding intermediates can
be made by cells based solely on the presence of M8B.
Moreover, according to results shown in Figure 8B, deman-
nosylation of Man9GlcNAc2 presumably occurs immedi-
ately after glycan transfer, before glycoproteins complete
their folding attempts, that is, before cells have to decide
whether to derive glycoproteins to the Golgi or to protea-
somes. M8B is the glycan present in S. cerevisiae ER -man-
nosidase, an ER-permanent resident protein (Valle´e et al.,
2000b), thus indicating that glycoproteins bearing that gly-
can are not necessarily bound to degradation.
Figure 9. CPY* degradation in S. pombe. Wild-type or indicated
mutant S. pombe cells expressing S. cerevisiae CPY* were labeled for
30 min with [35S]MetCys. Protein synthesis was stopped upon
addition of cycloheximide, and aliquots were withdrawn 0 and 30
min after addition of the protein synthesis inhibitor. Cells were
lysed and CPY* immunoprecipitated, run on SDS-PAGE, and sub-
mitted to autoradiography. KFN, DMJ, lactacystin, and MG132 (fi-
nal concentrations: 2.5 mM the first two drugs and 50 M the last
two drugs) were added 30 min and DTT (5 mM) 5 min before the
label. Recovery of CPY* in immunoprecipitates was normalized by
quantification of immunoprecipitated CNX from the same extracts.
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The role of M8B as a signal for protein degradation is even
more controversial in mammalian cells. As mentioned
above, the main evidence for such a role comes from the
observation that -mannosidase inhibitors such as KFN or
DMJ also inhibited misfolded glycoprotein degradation (Liu
et al., 1997; De Virgilio et al., 1999; Chung et al., 2000; Marcus
and Perlmutter, 2000; Fagioli and Sitia, 2001). Contrary to
what happens in both S. cerevisiae and S. pombe, where there
is a single -mannosidase in the ER and none in the Golgi,
two such activities, referred to as I and II, that produce M8B
and Man8GlcNAc2 isomer C (M8C, Figure 1), respectively,
have been described in the mammalian cell ER (Weng and
Spiro, 1993; Gonza´lez et al., 1999; Tremblay et al., 1999). In
addition, three other -mannosidases localize to the cis-
Golgi (referred to as IA, IB, and IC). These three -manno-
sidases are able to degrade Man9GlcNAc2 to Man5GlcNAc2
and are inhibited by both KFN and DMJ. Two of them (IA
and IC) yield M8A as first degradation product, whereas IB
yields both M8A and M8C (Figure 1) (Lal et al., 1998; Trem-
blay and Herscovics, 2000). The activities of cis-Golgi man-
nosidases are noteworthy because misfolded glycoproteins
may cycle between the Golgi and the ER before being di-
verted to proteasomes (Caldwell et al., 2001; Sato et al., 2001).
In addition, an endomannosidase (not inhibited by KFN or
DMJ) present in both the cis Golgi and in the ER-Golgi
intermediate compartment (ERGIC) may degrade
Glc1Man9GlcNAc2 (the GT reaction product) to M8A (Zuber
et al., 2000). M8A is unable to be reglucosylated by GT
because it lacks Man residue g (Figure 1). Because GT, CNX,
and CRT have been described to localize not only to the ER
but also to the ERGIC (Zuber et al., 2001), endomannosidase
degradation of misfolded glycoproteins may trigger their
release from the lectin anchors, thus driving them to protea-
somal degradation.
The variety of -mannosidases present in the mammalian
cell ER and cis-Golgi may explain, for example, that the
single N-glycan present in 3-hydroxy-3-methylglutaryl-CoA
reductase, an ER resident membrane glycoprotein, presents
the so-called microheterogeneity because Man8GlcNAc2,
Man7GlcNAc2, Man6GlcNAc2, and Man5GlcNAc2 glycans
were detected in the enzyme. M8B and a single
Man6GlcNAc2 isomer were the main species (32 and 43%,
respectively) (Bischoff et al., 1986). This result confirms that
glycoproteins residing in the mammalian cell ER for long
periods, as misfolded species do, may have substantial
amounts of glycans different from M8B and that those dis-
playing such glycans are not necessarily bound for degra-
dation. Furthermore, it has been determined that glycans in
glycoproteins subject to ERAD are processed to
Man6GlcNAc2 and Man5GlcNAc2 (Frenkel et al., 2003). Ad-
ditional observations also cast doubts on the role of M8B as
a signal for misfolded glycoprotein degradation in mamma-
lian cells. For example, it was reported that KFN and DMJ
delayed proteasomal degradation of a short-lived soluble
ribophorin I variant expressed in MadIA214 cells (Ermonval
et al., 2001). These cells transfer to proteins Man5GlcNAc2
instead of Glc3Man9GlcNAc2 (Figure 1); thus, no M8B can be
formed in them. It was also reported that addition of KFN
and/or DMJ delayed degradation of misfolded glycopro-
teins synthesized in the presence of glucosidase I and II
inhibitors (deoxynojirimycin and castanospermine) (Toku-
naga et al., 2000; Wilson et al., 2000). Because these com-
pounds prevent removal of glucose units from transferred
glycans, no M8B can be formed under the experimental
conditions used.
An alternative explanation provided for the role of man-
nosidases in irreparably misfolded glycoprotein disposal
assumes that, as the extensive glycan processing observed in
misfolded glycoproteins (formation of Man6GlcNAc2 and
Man5GlcNAc2) removes the residue to which GT adds the
Glc unit (residue g, Figure 1), ensuing liberation of mis-
folded glycoproteins from their CNX/CRT anchors would
allow their diversion to proteasomes (Frenkel et al., 2003). It
was recently reported that both S. cerevisiae and mammalian
ER -mannosidases I are not as specific as initially thought
because they are able to further degrade M8B (Herscovics et
al., 2002). It was also suggested that the enhanced misfolded
glycoprotein degradation observed upon overexpression of
mammalian ER mannosidase I in mammalian cells could be
a consequence of arresting GT-mediated reglucosylation
(Hosokawa et al., 2003). This alternative explanation is not
applicable to S. cerevisiae, a yeast lacking GT, or to S. pombe,
because the smallest glycan produced in this yeast
(Man7GlcNAc2, Figure 1) still conserved residue g. Further-
more, the above-mentioned reports according to which
KFN/DMJ inhibited degradation of misfolded glycoproteins
synthesized in the presence of glucosidase inhibitors argue
against this alternative explanation: as residues l-n (Figure 1)
block ER -mannosidase-mediated removal of residue g, no
effect of KFN/DMJ addition should had been observed.
All reports on this issue, including the present report, may
be best explained by assuming that the effect of ER manno-
sidase I on misfolded glycoprotein degradation is indepen-
dent of its enzymatic activity, that is, that ER mannosidase I
behaves as a lectin binding polymannose glycans of varied
structures, and belongs, together with its enzymatically in-
active homologue Htm1p/Mnl1p/EDEM, to a transport
chain responsible for delivering misfolded glycoproteins to
proteasomes. The crystal structure of S. cerevisiae ER -man-
nosidase revealed that the enzyme catalytic cavity interacted
with the glycan of an adjacent enzyme molecule (Valle´e et
al., 2000b). In addition, evidence was presented indicating
that KFN and DMJ occupy the same cavity (Valle´e et al.,
2000a). The observed effects of KFN and DMJ on misfolded
glycoprotein disposal could be due not to their activities as
ER mannosidase inhibitors but, because they are Man ho-
mologues, to inhibition of the ER mannosidase or/and
Htm1p/Mnl1p/EDEM putative lectin properties. Further-
more, the above-mentioned presence of a variety of different
N-glycan structures in irreparably misfolded glycoproteins,
the degradation of which is inhibited by KFN/DMJ, point
not to a restricted but rather to a broad specificity of the
putative ER lectins (both -mannosidase I and Htm1p/
Mnl1p/EDEM) involved in glycoprotein degradation.
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